0
0
30 words
0
Comments
Amgen stock fell Tuesday even after the biotechnology company easily beat quarterly earnings estimates and raised revenue guidance.
You are the first to view
https://www.barrons.com/articles/amgen-stock-revenue-guidance-588fb134
Create an account or login to join the discussion